Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype

Frank C. Sciurba

Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, University of Pittsburgh, Pittsburgh

Gerard J. Criner

Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia

Stephanie A. Christenson

Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, School of Medicine, University of California, San Francisco, San Francisco, CA, USA.

Fernando J. Martinez

Alberto Papi

Department of Translational Medicine, Respiratory Medicine Section, University of Ferrara, Ferrara, Italy

Nicolas Roche

Jean Bourbeau

Respiratory Epidemiology and Clinical Research Unit, Research Institute McGill University Health Centre, McGill University, Montreal

Stephanie Korn

Clinical Research Center, Respiratory Medicine, Institut für Klinische Forschung Pneumologie Mainz, and Thoraxklinik Heidelberg, Heidelberg, Germany

Mona Bafadhel

King’s Centre for Lung Health, School of Immunology and Microbial Sciences, King’s College London

MeiLan K. Han

Pulmonary and Critical Care, University of Michigan Health System, Ann Arbor

Stefanie Kolterer

Specialty Care, GSK, London

Karen Miller

Specialty Medicine Development Leader Group, GSK, London

Dalal Mouneimne

Clinical Sciences — Respiratory and Specialty, GSK, London

Joanne Fletcher

Clinical Sciences — Respiratory and Specialty, GSK, London

Bhabita Mayer

Biostatistics, GSK, London

Jeff Min

Clinical Sciences — Respiratory, GSK, Waltham, MA

Ian D. Pavord

NIHR Oxford Respiratory Biomedical Research Centre, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom